Riskpilot← Back to searchSign inGet full accessScandinavian Diagnostics Holding AB
ABActiveOrg 5592511603Economic activity was not specified by tax authority · NACE 0000Est. 20200 employees
Revenue 2024
SEK 0
EBITDA margin
—
+50% vs 2023
Equity ratio
57.0%
Financial strength
Net profit 2024
SEK 899K
+50% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -1K | +50% |
| Net profit | SEK 899K | +50% |
| Total assets | SEK 6M | +0% |
| Equity | SEK 3,4M | +17% |
| Employees | 0 | — |
Legal name
Scandinavian Diagnostics Holding AB
Org number
5592511603
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
6 april 2020
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall förvalta dotter och intressebolag samt förvalta värdepapper och bedriva därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −2 | −1 | −1 | −2 | −1 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −2 | −1 | −1 | −2 | −1 |
| Net financials | 2 000 | 2 500 | — | 600 | 900 |
| Profit before tax | 1 998 | 2 499 | −1 | 598 | 899 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 1 998 | 2 499 | −1 | 598 | 899 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 7 248 | 8 547 | 6 746 | 6 044 | 6 043 |
| Equity | 2 048 | 3 347 | 2 746 | 2 944 | 3 443 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 5 200 | 5 200 | 4 000 | 3 100 | 2 600 |
| Total debt | 5 200 | 5 200 | 4 000 | 3 100 | 2 600 |
EBITDA margin
-100000.0%
This company
15.8%
Market median
-633011% vs market
20202024
Equity ratio
57.0%
This company
38.2%
Market median
+49% vs market
20202024
Return on equity
26.1%
This company
18.4%
Market median
+42% vs market
20202024
Net profit margin
89900000.0%
This company
8.1%
Market median
+1109876443% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.76×
This company
0.62×
Market median
+23% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-04-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LS | Audit | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Scandinavian Diagnostics Holding AB 
Scandinavian Diagnostics ABBoard members of Scandinavian Diagnostics Holding AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Stefan Johansson | Audit | 0 companies |
| Tonny Nielsen | Board of Directors | 0 companies |
| Roger Laszlo Keszei | Board of Directors | 0 companies |
| Hanna Camilla Larsson | Board of Directors | 0 companies |
| Mats Ingemar Racklin | Chairman | 0 companies |